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Tissues obtained from 34 human renal allografts 
by biopsy, 1 to 31 months after transplantation, were 
studied by histologic, immunofluorescence, and im-
munoferritin techniques. Our purpose was to gain 
more precise information concerning the localization 
of immunoglobulins and complement in glomeruli 
and to describe the associated tubular and vascular 
changes. 
1. Localization of fluorescein-labeled antibodies 
(Fl-Abs) to IgG, IgM, ,sIC, and C'Iq was seen in 
glomeruli from 25 allografts and showed the follow-
ing distribution of patterns: (a) diffuse linear, four; 
(b) diffuse granular, four; (c) focal linear, six; (d) 
focal granular, six; and (e) indeterminate, five. Fer-
ritin-conjugated antibodies (Fer-Abs) localized in 21 
allografts. Electron microscopic findings correlated 
with the foregoing immunofluorescence patterns. (a) 
Fer-Abs were bound on the endothelial side of the 
glomerular basement membrane and in the subendo-
thelial space. (b) Fer-Abs were bound in subendo-
thelial and subepithelial deposits similar to those seen 
in experimental acute or chronic serum sickness. (c 
and d) Fer-Abs were seen in the subendothelial space 
and mesangial matrix. Deposits were present in these 
Recently an immunofluorescence study of 71 human 
renal allografts treated with immunosuppressive agents 
and two renal isografts has been reported.36 The oc-
currence of glomerular localization of fluorescent anti-
bodies to IgG and IgM, to fractions of human comple-
ment, and to fibrinogen was described. The findings, 
correlated with light and electron microscopic studies, 
were consistent with the hypothesis that circulating 
immunoglobulins, complement, and fibrinogen may play 
a role in human chronic allograft rejection. 
The purpose of the present immunopathologic stud-
ies by morphologic, immunofluorescence, and immuno-
ferritin techniques of 34 human renal allografts is to 
gain more precise information concerning the locali-
. zation of immunoglobulins and complement in glo-
meruli and to describe some tubular and vascular 
changes which also are associated with the presence of 
areas and some bound Fer-Abs. The two groups were 
not readily separable on the basis of immunopatho-
logic data. (e) Fer-Abs were mostly seen in the 
mesangial area. 
2. Nine allografts displaying little or no binding 
of FI-Abs failed to bind Fer-Abs. 
3. Small amounts of fibrinogen were found in only 
six allografts, three of which showed diffuse granular 
fluorescence. 
4. In 12 allografts either Fl-Abs or Fer-Abs or 
both were bound in walls of blood vessels. The posi-
tion of these reactants was in foreign deposits and in 
basement membranes of arteries and veins. 
The immunopathologic findings seem to support 
best the hypothesis that damage to allografts is asso-
ciated with deposition, in glomerular and vascular 
structures, of circulating antigen-antibody complexes 
which might contain, in part, transplantation antigens. 
Additional key words: Human renal allografts, 
Transplantation complexes, Glomerulonephritis trans-
mission, IgG, IgM, Complement, Immunofluores-
cence, Immunoferritin. 
immunoglobulins and complement. The data obtained 
are useful in assessing possible pathogenetic mechanisms 
responsible for damage of the renal grafts. 
MATERIALS AND METHODS 
PATIENT MATERIAL 
Biopsy specimens from 34 human renal allografts 
have been studied by light and electron microscopy 
and by immunofluorescence and immunoferritin tech-
niques. Of the allografts 20 were from the University 
of Colorado Medical Center, Denver, Colorado, 9 from 
the St. :Vlary's Hospital, London, England, and 5 from 
the Royal Victoria Hospital, Montreal, Canada. Pre-
liminary immunofluorescent findings of 15 allografts, 
LDI09, LDI08, LDI07, LDllO, LD1l4, LD71, LD70, 
LD68, M31, M32, M33, MS, M30, AF, and RM, have 
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been reported. 36 The Denver patients, indicated by 
the letters LD followed by a number, received kidneys 
from living donors. The Montreal patients, identified 
by the letter M before the number, and London pa-
tients, designated with their initials, were given kidneys 
from cadavers. The spleens of all of the Denver and 
London patients had been removed. The thymus was 
removed in nine of the Denver patients. At the time 
of the biopsy, the allografted patients were receiving 
50 to 200 mg. of azothioprine and 2.5 to 25 mg. of 
prednisone a day. Fourteen patients were treated with 
one antihypertensive drug or more (chlorothiazide, 
hydralazine, reserpine, and methyldopa). Five patients 
were receiving antihuman lymphocyte globulin.an Ta-
bles 1 and 2 contain additional data. 
ANTISERA USED IN IMMUNOFLUORESCENT AND 
1 :\Il\IUNOFERRITIN STUDIES 
The following antisera used for fluorescein or ferritin 
labeling were either kindly supplied by investigators 
or were purchased from commercial laboratories. Rab-
bit antiserum to human IgG was supplied by Dr. A. J. 
L. Strauss;41 goat antiserum to human IgG, by Dr. C. L. 
Christian;~!g rabbit antiserum to human fibrinogen, by 
Dr. F. Gorstein;17 rabbit antiserum to human C'lq, by 
Drs. J. H. Morse and C. L. Christian;~!i rabbit or goat 
antiserum to human IgM, from Hyland Laboratories, 
Los Angeles, California; and rabbit antiserum to 11U-
man jjlC and jjlA, from Hoechst Pharmaceuticals. The 
globulin fractions were separated from these antisera 
and from normal rabbit and goat sera and were con-
jugated with fluorescein42 or ferritin4 according to 
methods previously described. 
All ferritin-conjugated globulins were subjected to 
immunoelectrophoretic tests with antibody to rabbit or 
goat globulin to determine successful conjugation. They 
were also tested for their immunologic reactivity with 
their specific antigens before use in electron micro-
scopic studies, either by immunoelectrophoresis or by 
the Ouchterlony technique.4 Ferritin-labeled normal 
rabbit and goat globulins were used in control tests. 
TISSUE PROCESSING FOR LIGHT AND ELECTRON l\lICROSCOPY 
Tissue was obtained from each renal graft by open 
biopsy after transplantation at the times indicated in 
Tables 1 and 2. Each tissue was divided into four 
parts. The first portion was fixed in 10 per cent neutral 
formalin or buffered for mol saline, was embedded in 
paraffin wax, and was serially sectioned and stained 
with hematoxylin and eosin, periodic acid-Schiff reagent, 
vVeigert's stain, and methyl green-pyron in. The second 
part of the biopsy was immediately fixed in PaIade's 
buffered osmium tetroxide and embedded in Epon 812. 
Sections 0.5 /L thick, cut from these blocks, were stained 
with azure II and examined by light microscopy. Thin 
sections for electron microscopy were stained with lead 
hydroxide, uranyl acetate, or a combination of both 
and were examined with a Siemens-Elmiskop IA or 
with a Philips EM-300 electron microscope. The third 
portion of tissue was quick frozen in a bath of alcohol 
and Dry Ice or in liquid nitrogen. Frozen sections 
4 /L thick were cut in a cryostat and stained with 
fluorescein-conjugated antisera according to techniques 
already describeElK4~ The fourth portion of tissue was 
immediately treated with ferritin-conjugated antibodies 
while fresh, before processing for electron microscopy.4 
Prefixation and the particular handling of the tissue 
necessary for the preservation of the antigenicity and 
permeability to ferritin-antibody conjugates account for 
the presence of artifacts in many of the electron micro-
graphs. 
RESULTS 
Tissue sections from biopsies of the· 34 allografts 
examined in these studies were stained with fluorescein-
and ferritin-labeled antibodies to IgG, IgM, jjlC, C'lq, 
and fibrinogen in order to determine which of these 
antigens were present in excess of normal amounts in 
the glomeruli. It was found that: (I) 25 of the tissues 
bound two of the antisera or more in various areas of 
the glomeruli; and (2) among the other nine tissues, 
there were six which bound none of the antisera, 
whereas the remaining three bound only one or two 
antisera in trace amounts. 
TWENTY-FIVE ALLOGRAFTS SHOWING LOCALIZATION OF 
IMMUNOGLOBCLINS AND COMPLEMENT IN GLOMERULI 
The 25 biopsies which bound labeled antisera have 
been subdivided into five groups on the basis of the 
pattern of localization of the fluorescein-labeled anti-
bodies. The frozen sections from the first 10 allografts 
(Table I) bound the antisera in the glomeruli with 
linear distribution. (1) In four instances, LD84, RM, 
LD93, and LD7, there was diffuse linear staining. The 
allografts from patients LD84, RM, and LD93 had only 
slight or moderate glomerular lesions characterized by 
diffuse, fine, linear subendothelial changes which are 
shown in Figure 1, a micrograph of a biopsy from 
LD84 taken 2Y2 years after transplantation. The sub-
endothelial space contains fine deposits of material 
morphologically similar to the basement membrane. 
Figure 2, inset, displays the appearance of linear fluores-
cence in a piece of the same biopsy stained with fluores-
cein-labeled antibody to IgG, whereas in Figure 2, fer-
ritin-conjugated antibody to IgG is present on the 
endothelial side of the basement membrane and in the 
subendothelial space. This localization may account for 
a linear fluorescent pattern which was not as sharp as 
that seen in sections from patients with Good-
pasture's disease. Fluorescein- and ferritin-labeled anti-
bodies to IgG showed the strongest glomerular binding. 
Linear staining of tubular basement membranes also 
was observed in allografts LD93 and RM. The fourth 
allograft with linear fluorescence, LD7, had more se-
vere subendothelial and mesangial changes. (2) In six 
allografts, LD1l4, LDI07, AE, LD71, MS, and LD102, 
there was focal linear fluorescence. The distinction be-
tween focal linear and granular staining was often 
difficult. As a rule, the cases in which even a few 
granules could be detected were believed to be granular. 
The severity of the glomerular changes could not be 
correlated with the intensity of the fluorescence, which 
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FIG. I. Kidney biopsy of allograft LD84, 2 years and 6 months 
after transplantation. The subendothelial space of the glomerular 
capillary wall contains fine deposits of material (arrows) morpho· 
logically similar to the basement membrane (8M). c/, Capillary lu-
men ; EP, epithelium. X 17,000. 
FIG. 2. Allograft LD84. The upper inset displays a diffuse, linear 
binding of fluorescent antibody to IgG in capillary walls of one 
glomerulus. The lower inset illustrates a few loops of the same glo-
merulus at higher magnilkation. In the electron micrograph, parts 
of two glomerular capillary loops from tissue treated with ferritin-
conjugated antibody to IgG are seen. Ferritin granules are mainly 
localized on the endothelial side of the basement membranes (BM). 
c/, Capillary lumen; EP, epithelium; EN, endothelium. Figure 2, 
X30,OOO; upper inset , X300; lower inset, X600. 
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was usually slight or moderate. In the most severe cases, 
LD71 and LD 102, pseudopods of the mesangial cells 
extended into the subendothelial space, and morpho-
logic similarities between the material present in the 
subendothelial space and mesangial matrix were seen. 
In some capillary loops, LD 102, a continuous band of 
newly formed basement membrane-like material lay 
close to the endothelial cytoplasm (Fig. 3). Ferritin-
conjugated antibodies, bound to the endothelial side 
of the basement membrane and in the newly formed 
basement membrane-like material (Fig. 4), as well as 
in the mesangial matrix, showed focal distribution. In 
the basement membrane and in the mesangium, some 
electron-dense deposits bound ferritin-conjugated anti-
bodies, whereas others did not (Fig. 5). This finding 
may be due to the problem of penetration by the 
labeled antibody or to variation of the composition of 
the deposits, the latter of which may explain the diffi-
culty in separating allografts with focal linear from 
those with focal granular fluorescence. 
Fluorescein-labeled antibodies to IgG and IgM and 
to complement showed granular localization in glomeru-
lar structures of 10 allografts listed in Table 1. (3) Four 
of these, LD89, DH, LD85, and LDI1O, had a diffuse 
granular fluorescence. The immunoelectron microscopic 
data suggested that the granular fluorescent pattern 
was due to localization of labeled antibodies in aggre-
gates of foreign material forming deposits in different 
parts of the glomeruli. Thus in allografts LD89 and 
LD110, electron-dense deposits binding the ferritin-con-
jugated antibodies were seen within the basement 
membrane (Fig. '6) or on its endothelial side only. In 
addition, subendothelial and mesangial changes, similar 
to those already described in allografts with linear 
fluorescence (Figs. 1 to 5), were present (Fig. 7). In 
contrast, the other two allografts with diffuse granular 
fluorescence, LD85 and DH, exhibited a pathology 
characteristic of acute proliferative, LD85 (Fig. 8), or 
membranous, DH, glomerulonephritis. Fluorescein- or 
ferritin-conjugated antibodies to IgG and IgM and to 
complement were localized in subepithelial and sub-
endothelial deposits. The inset of Figure 9 reveals a 
section of the allograft of LD85 stained with fluorescein-
labeled antibody to f3IC. Fluorescent deposits are in the 
walls of capillaries in a glomerulus and also in Bow-
man's capsule. In Figure 9 there is binding of ferritin-
FIG. 3. Kidney biopsy of allograft LD102, 1 year and 8 months 
after transplantation. The subendothelial space of the basement 
membrane is occupied by foreign material which is more electron· 
dense (arrowheads) in proximity of the endothelial cytoplasm (en): 
M, Mesangial cell nucleus; cl, capillary lumen. x 2,900. 
FIG. 4. Allograft LDI02. Ferritin-conjugated antibody to IgM 
(arrows) is localized on the endothelial side of the basement memo 
brane (BM) and in the newly formed basement membrane-like ma-
terial close to the endothelial cytoplasm (EN). Organelles present in 
the subendothelial space (ss) do not bind the ferritin conjugate. ItP, 
Epithelium. x 32,000. .. 
FIG. 5; Allograft LD102. Ferritin-conjugated antibody to IgM.·is 
seen in the subendothelial spaces (ss). The electron-dense deposits 
(D) do not contain ferritin granules. cl, Capillary lumen; EP, epi-
thelium. x28,000. 
FIG. 6. Kidney biopsy of allograft LD89, 2 years and 4 months 
conjugated antibody to C'lq in subepithelial deposits. 
The glomerular basement membranes, the basement 
membrane of the Bowman's capsule, and the mesangial 
matrix .. did not contain ferritin granules. In the same 
two allografts, deposits present within or on the outer 
side of Bowman's capsule (Fig. 10) bound fluorescein-
(Fig. 11) and ferritin-conjugated (Fig. 12) antibodies. 
Similar binding was observed in precipitates contained 
in the tubular lumina, LD85 (Figs. 13 to 16), and in 
deposits present within or on the outer side of tubular 
basement membranes, LD85, LD89, and DH (Figs. 17 
to 19). The tubular deposits were not autofluorescent,7 
and in no instances were there fibrils similar to those of 
amyloid observed by electron microscopy. 
In allograft LD89, removed 2 months after biopsy, it 
was found that immunoglobulins and complement were 
no longer bound to the tissues. (4) Six allografts, LDI06, 
LD90, LD94, LD68, LD70, and M31, had focal granular 
fluoresce,nce with subendothelial and mesangial changes 
which were indistinguishable from those of allografts 
with focal linear fluorescence. Ferritin-conjugated anti-
bodies to IgG and IgM and to complement were local-
ized in electron-dense aggregates present in the sub-
endothelial space and in the mesangium, indicating that 
the immunofluorescent pattern seen resulted from bind-
ing of the conjugate in the same areas. In addition, 
ferritin-labeled antibodies were also seen in the sub-
endothelial space and in the mesangial matrix. 
In the last five allografts, the immunofluorescent pat-
tern was considered indeterminate. (5) The distribution 
of the colljugated antibody to IgM and complement in 
glomerular capillary walls in LD109, LD108, BF, M30, 
and M33 was neither linear nor granular. Ferritin-
labeled antibody was seen only in allografts of BF and 
M30 and was mainly present in the mesangial area. 
NINE ALLOGRAFTS WITH LITTLE OR No LoCALIZATION OF 
IMMUNOGLOBULINS OR COMPLEMENT 
The renal biopsies from the nine patients listed in 
Table 2 revealed histopathologic changes in glomeruli 
which were little more than minimal, although similar 
in kind, if not in amount, to some of the allografts 
presented in Table 1. Subendothelial accumulations of 
amorphous material similar to the mesangial matrix and 
increased amount of mesangial matrix were observed. 
. Six allografts, GW, LD78, LD87, DP, Cj, and VA, were 
after transplantation. The picture illustrates two electron-dense de-
posits (D) within the thickerurd glomerular basement membrane 
(BM). Ferritin-conjugated antiOody to IgM is present in the deposits, 
but not in the basement membran~I BS, Bowman's space; EP, epi-
thelium; EN, endothelium. X30,0Q0. 
FIG. 7. Allograft LD89. The il1set illustrates a frozen section 
stained with fluorescein-conjugated antibody to IgM which is local-
ized in the capillary walls forming two parallel lines (arrows) cor-
responding to the "splitting" of glomerular basement ·membrane 
shown in Figure 3, cl, Capillary lumen; BS, Bowman's space. In the 
electron micrograph ferritin-conjugated antibody to IgM is localized 
(arrows) on the endothelial side of the basement membrane (BM) 
and in, the newly formed basement membrane· like material close to 
the endothelial cytoplasm (EN). The organelles in the subendothelial 
space (ss) do not bind ferritin. EP, Epithelial foot processes. Figure 
7, X28,000; inset, XI,IOO. 
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FIC. 8. Kidney biopsy of allograft LD85, 2 years and 6 months 
after transplantation. Proliferating cells partially obliterate the cap-
illary lumina (ct). Subendothelial (arrows) and focal subepithelial 
(asterisks) deposits are visible. In the inset there is granular fluores-
cence resulting from staining of one glomerulus of the same allograft 
with fluorescein -conjugated antibody to tliC . Figure 8, X 5,OOO; in-
se t, X400. 
FIG. 9. Allograft LD85. The inset illustrates part of a frozen sec-
tion stained with flourescein -labeled antibody to tliC. Fluorescent 
granular deposits are seen along the wall of a glomerular capillary 
(c t) . Other deposits are present in Bowman 's capsule (Be ). BS, Bow-
man's space. The electron micrograph displays part of the same tis-
sue treated with ferritin-conjugated antibody to C' lq. Ferritin gran-
ules are localized in the subepitheli a l deposits (D), whereas they are 
not bound in the basement membrane (BM). EP, Epithelium. Fig-
ure 9, X50,000; inset, X 1,000. 
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fi G. 10. Allograft LD85. Deposits (D) of foreign material are pres· 
ent within the basement membrane of Bowman 's capsule. The glo· 
merular bascmcnt membranes (BM) are thickened. d, Capillary lu -
men. x3,000. 
Flc. II. Frozen section of allograft LD85 trcated with fluorescein-
conjugated antibody to (JIC. The small anows point to deposits in 
the Bowman's capsule, probably similar to those seen in Figure 10. 
The fluoresceinatccl antibody is also bound in the wall of the affer-
ent arteriole (lm'ge anow) and in the walls of some tubules. x450. 
VIG. 12. Allograft LD85. Tissue treated with ferritin -conjugated 
antibody to C'lq. In the inset, a deposit (D) is localized within the 
basement mcmbrane of the Bowman's capsule (BB). BS, Bowman's 
space; ct, the lumen of a glomerular capillary; BM, a glomerular 
basement membrane. Tn the enlarged electron micrograph, ferritin 
granUles are bound ill the foreign deposit (D). The basement mem-
brane (BM) of the Bowman's capsule and the parietal epitheli urn 
(EP) do not bind ferritin. BS, Bowman's space. Figure 12, x35,OOO; 
inset, X4,500. 
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Note: Figures 13 to 16 illustrate cross·sections of renal tubules of 
al.lograft LD85. 
FIG. 13. In the inset, a frozen section was stained with fluorescein-
conjugated antibody to !'lIe. Aggregates of material present within 
the tubular lumen (TL) and parts of the tubular basement mem-
brane (arrows) are stained. In the electron micrograph of Figure 13, 
the lumen of a tubule is a lmost completely obliterated by granular 
material (D). EM, Pans of tubular basement membrane. The two 
boxed areas of Figure 13 are illustrated at higher magnifications in 
Figures 14 to 16. Figure 13, X4,000; inset , X250. 
FIG. 14. A,: enlargement of th e boxed area at the tot) of Figure 
13, ferritin-conjugated antibody to C'lq is bound to aggregates of 
electron-dense material (D) present within the tubular lumen . N, 
Part of the nucleus of an epithelial cell (EP). X45,000. 
FIG. Ii). The ferritiu conjugate is bound to aggregates of material 
contained in the tubular lumen (D) and to the tubular basement 
membrane (BM). Squm'e boxed area is detailed in Figure 16. EP, 
Epithelial cell. x20,000. 
FIG. 16. Detail of square boxed area in Figure 15. The nature of 
the circular or elongated profiles, 600 to 800 A in diameter, visible 
in Figures 14 to 16 (arrows) is unknown. X65,000. 
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Note: Figures 17 to 19 are of allograft LD85. The electron micro-
graphs illustrate sections of tissue treated with ferritin-conjugated 
antibody to C'lq. 
FIG. 17. Electron-dense deposits (d) are present within the tubular · 
basement membrane (BM). In this picture, the eliptical deposit (D) 
seems located between the tubular basement membrane and the epi-
thelial cytoplasm (EP). At higher magnification, however, this de-
posit proved to be intramembr<\nous. I , Interstitium. ' X2,800. 
FIG. 18. Electron-dense deposits (D) lie in the interstitium (l), 
along tubular basement membranes (BM). TL , Tubular lumen; c, 
three peri tubular capillaries. X I ,500. 
FIG. 19. At higher magnification this figure reveals the part of the 
tissue included in the boxed OTeo of Figure 18. Ferritin-labeled anti-
body is localized in the deposit (D) and in \he basement m em brane 
(8M) . N, Nucleus of an epithelial cell. In the inset, a frozen section 
of the same allograft is stained with fluorescein-l abeled antibody to 
i3IC. Granular staining of tubular walls is visible. Figure 19, 
X30,OOO; inset, X250. 
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negative for all five immunofluorescent sera tested, and 
staining was minimal in the other three, M32, LD 103, 
and DC. Ferritin-conjugated antibodies were not bound 
in the renal tissue of any of the nine allografts. 
PRESENCE OF FIBRINOGEN IN ALLOGRAFTS 
Fluorescein-labeled antibody to fibrinogen was bound 
in only six instances in the glomeruli of the 34 allo-
grafts. In four the binding was minimal; in the other 
two it was rated only one plus. The greatest concen-
tration of fibrinogen was observed in the allografts with 
generalized granular distribution of immunoglobulins 
and complement. It was present mainly in the mesan-
gial areas of LD85 and LDllO. Ferritin-labeled anti-
body to fibrinogen was tested in seven cases but did 
not localize in these tissues. 
LOCALIZATION OF IMMUNOGLOBULINS AND COMPLEMENT IN 
VESSEL ,'" ALLS 
Morphologic and immunologic changes were fre-
quently observed in glomerular and interstitial arteri-
oles. In 12 allografts fluorescein- and/or ferritin-labeled 
immunoglobulins and complement were demonstrable 
in these areas, as is illustrated in Figures 20 to 29. 
The inset of Figure 20 exhibits a section of allograft 
LD71 (1 year and 10 months old) in which the wall of 
an afferent arteriole was stained with fluorescent anti-
body to IgM. Figures 20 and 21 display an arteriole 
from the same kidney in which ferritin-conjugated an-
tibody to IgM has been bound in the basement mem-
brane. Conjugated antibodies to immunoglobulins and 
complement were seen in the basement membranes of 
arterioles, in the normal or increased amount of base-
ment membrane-like material lying between the cells 
of the media, and in the basement membranes of in-
terstitial capillaries and venules (Figs. 22 to 24). The 
antibody to complement gave more uniform localiza-
tion. In two allografts, LD85 and LD89, granular de-
posits (Fig. 25), binding fluorescein- (Fig. 26) and 
ferritin-conjugated antibody (Figs. 27 to 29) to C'lq 
were present among the smooth muscle cells of the 
media or near the walls of a vein and arteries. Control 
tests were consistently negative (Fig. 30) in all instances. 
DISCUSSION 
Examination of biopsies from 34 allografts by im-
munofluorescence and immunoferritin techniques leads 
to a separation of the tissues into two major groups. 
The first contained 25 allografts in which the presence of 
excess immunoglobulins and complement was demon-
strated in the glomerular capillary walls, whereas the 
second consisted of nine tissues in which there was 
minimal or no evidence for the presence of these pro-
teins. The major group was subdivided on the basis 
of the distribution of the immunoglobulins and com-
plement in the glomeruli. 
When tested with fluorescein-labeled antibody, 10 of 
the tissues showed linear localization in the capillary 
loops, which was widely dispersed in four and was focal 
in distribution in six. Another 10 showed granular 
distribution in capillary loops, which also was widely 
dispersed in four and focal in six. The other five 
tissues could not be classified on the basis of what was 
seen in the fluorescent microscope. The localization 
appeared to be mainly in the mesangial area. 
The electron microscopic studies gave precise informa-
tion concerning the lesions in these allografts and the 
specific area of localization of the immunoglobulins and 
complement. In allografts of the first four patients 
(Table 1), the most characteristic glomerular changes 
consisted of fine subendothelial deposits, subendothelial 
accumulation of material morphologically similar to 
mesangial matrix, and increase of the mesangial matrix. 
Immunoglobulins and complement were localized, by 
the ferritin-labeled antisera, on the endothelial side of 
the basement membrane and in the subendothelial de-
posits. 
In four allografts, LD89, DH, LD85, and LDllO, 
granular localization of fluorescent antibodies to im-
munoglobulins and complement was also diffuse. The 
granular appearance of the fluorescence was reminiscent 
of pathology produced by circulating antigen-antibody 
complexes.6• 11. 12. 14 By the immunoferritin technique, it 
was seen that in allografts LDllO and LD89 there were 
no subepithelial deposits, and the immunoferritin studies 
showed that the granular pattern seen by immunofluo-
rescen~e ~esulted from staining of immune deposits pres-
ent wIthm glomerular basement membranes, in suben-
dothelial spaces, between proliferating cells, and in the 
mesangial areas. By contrast, in allografts LD85 and DH 
subepithelial deposits binding the labeled antibodies char-
acteristic of acute, LD85, or chronic, DH, serum sick-
ness were also present. 
The separation of six allografts with focal linear 
fluorescence from six with focal granular fluorescence 
was often difficult, and the changes detected by light 
and electron microscopy were not distinctive. Subendo-
~helial and basement membrane deposits were present 
m both groups. Some of the deposits bound ferritin-
conjugated antibodies, whereas others did not. This 
may be due to the lack of penetration of ferritin 
conjul?ates or to tl~e variation in the composition of the 
dep~sltsK The v~nable capacity of the foreign deposits 
to bmd. the conjugates .may account for the difficulty in 
separatmg allografts WIth focal linear from those with 
focal granular fluorescence. 
Two of the five allografts in which localization of 
fluorescein-labeled antibodies could not be classified as 
lin~ar or granula~ also bound ferritin-labeled antibody 
to Immunoglobulms and complement. The localization 
of these antibodies was mainly in the mesangial area. 
Three of the nine allografts (Table 2) bound only 
minimal amounts of antibodies to immunoglobulins or 
complement in glomerular structures by the immuno-
fluorescence technique. Ferritin-conjugated antibody was 
not found in any of the tissues. These allografts, how-
ever, had mesangial and subendothelial changes as well 
as vascular changes similar to slight or moderate changes 
seen in some of the allografts in which immune globu-
lins and complement were bound. It has been proposed 
that nonimmunologic factors may be partially or wholly 
responsible for chronic renal graft rejection.15• 37 How-
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F[G. 20. Biopsy of allograft LD71, 1 year and 10 months after 
transplantation. The inset illustrates the localization oE fluorescent 
antibody to IgM in the wall of an afferent glomeruJar arteriole. 
Fluorescent antibody was not seen in the glomeTulus. The electron 
micrograph displays a cross-section of an afferent arteriole in the 
same allograft. Tissue treated with ferritin-conjugated antibody to 
IgM . The boxed area is shown at higher magnification in Figure 21 . 
Figure 20, X2,500; inset , X 250. 
FIG. 21. Allograft LD71. Higher magnification of the boxed area 
of figure 20. Ferritin granules are localized in the basement mem -
brane (BM) of the arteriole. EN, Endothelium. X33,000. 
FIG. 22. A\lograft L.D 102. Tissue treated with ferritin·conjugated 
antibody to IgM. The picture exhibits an oblique section oE a capil-
lary (e) and of a venule (v) in the interstitium, and the • indicates 
basement membran e- like material interposed between capillary 
ami venule. The square and ,.eetangulm· boxed areas are illustrated 
at higher magnifications in Figures 23 and 24, respectively. X I,OOO . 
fIGS. 23 AND 24. Allograft LDI02. Ferritin-conjugated antibody 
to IgM is localized in the basement membrane-like material inter-
posed between [he capillary and the venule (asterisk , fig. 23, 
x 28,000) and in the basement membrane (BM) of the capillary. The 
inset of Figure 24 reveals the localization oE fluorescent antibody to 
IgM in the wall of an intertubular capillary. Figures 23 and 24, 
x 36,000; inset of Figure 24, X200. 
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FIG. 25. Allograft LD8:>. Cross-section of the wall of an artery. L, 
Lumen of the vessel; D, a granular d eposit between the smooth mus-
cle cells (!l1:) of the media. X2,000. 
FIG. 26. Frozen section of allograft LD85 treated with fluorescein-
conjugated antibody to C'lq. Granular deposits are localized in the 
wall of an artery between the autofluorescent elastica interna and 
elastica externa (arrows). X250. 
FIGS . 27 TO 29. Allograft LD85. Tissue treated with ferritin-con-
jugated antibody to C'lq. Cross-section of an artery. Fore ign depos-
its (D) are present between the smooth muscle cells of the media. L, 
Lumen of the vessel; aste"ish , the thickened subendothelial space 
which probably contains the basement membrane and the elastica 
interna. Figures 28 anel 29 represent higher magnifications of the two 
boxed areas of Figure 27. EN, Endothelium. Ferritin-conjugated 
antibody to /3 1 C is bound in the subendothelial space and the 
deposit, respectively. Figure 27, X I,300; Figures 28 and 29, 
X 36,000. 
FIG. 30. Allograft LDB5. Tissue treated with ferritin-conjugated 
normal goat globulin. Only a few ferritin granules (circles) are pres-
ent in the basement membranes (EM) and in the focal subepithelial 
deposit (D). Other ferritin granules (arrowhead) are v;sibfe in the 
Bowman's space (RS). X37,000 . 
.. "-K----I-~~-----~----­
- ------ - --------- - ---- --
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ever, failure to demonstrate immune reactants at one 
time does not rule out previous immunologic activity. 
It has been repeatedly observed in experimentaFG and 
Imman :l8 glomerulonephritis, as well as in human renal 
allografts, LD89, that detectable amounts of immuno-
globulins and complement may have a short life. Their 
disappearance may not necessarily coincide with clini-
cal and morphologic recovery. This may be particularly 
true in patients treated with immunosuppressive agents. 
The present study of human kidney transplants does 
not contribute information concerning the specificity of 
the immunoglobulins found. It still is not known which 
antigen or antigens are involved or if true antigen-anti-
body complexes are always presentK~O The immuno-
ferritin studies, however, have given precise information 
as to where the immunoglobulins and complement are 
found. The data presented here suggest some directions 
which may be given to hypotheses raised concerning the 
antigens and/or mechanisms causing the immunologic 
reactions. 
The diffuse linear staining of glomerular capillary 
walls, obtained with fluorescent antibodies to immuno-
globulins and complement in some of the grafts, was 
similar to that observed in glomerulonephritis produced 
by antibodies directed against antigens of the basement 
membrane as in Goodpasture's disease, primary nephro-
toxic nephritis, or against antigens fixed to the base-
ment membrane (second phase of nephrotoxic nephri-
tis). An attractive hypothesis to account for the linear 
staining seen in the biopsies of allografts described 
here is that antibodies to glomerular basement mem-
brane~T may be responsible for the subendothelial and 
mesangial lesions. The staining, however, was not as 
sharp as that seen in antiglomerular basement mem-
brane pathologyK~tg Furthermore, the ferritin studies 
indicated that the immunoglobulins localized more in 
the subendothelial space than in the glomerular base-
ment membrane proper, which might rule out basement 
membrane as the exclusive specific antigen involved in 
this pathology. There are two clinical observations 
which also throw doubt on the hypothesis that the 
reaction between basement membrane anc! specific anti-
body is the only cause of the observed linear localiza-
tion. The first of these is that subendothelial and 
l1lesangial lesions were observed as well in allografts of 
patients who had not suffered from glomerulonephritis 
as, for example, M8. 3G The second is that significant 
correlation existed between incompatibility of host and 
donor and the occurrence of renal damage.32 
Recently Koffler, Agnello, Carr, and Kunkel24 reported 
the results of an immunofluorescence study of renal 
tissues, obtained either by biopsy or at autopsy from 
patients with systemic lupus erythematosus. Biopsy 
specimens from three kidneys out of 19 and both 
necropsy specirnens exhibited linear deposition of anti-
body to IgG in the glomerular capillary walls. Citrate 
buffer eluates from biopsy and necropsy specimens did 
not contain demonstrable antibody to basement 
membrane. Thus in some phases of systemic lupus 
erythematosus, a disease probably due to antigen-anti-
bod y com plexes, linear localization may nevertheless 
occur. Evidence could not be obtained that this linear 
localization was associated with antibody to basement 
membrane. 
A second hypothesis to explain the immunologic 
findings is that the pathology described in this group 
of allografts is initiated and/or maintained by circulat-
ing antigen-antibody complexes. Inasmuch as the anti-
gens which may have participated in the formation of 
circulating immune complexes are unknown, the pos-
sibility that in some cases an immune complex glomeru-
lonephritis of the recipient may have been transmitted 
to the graft cannot be excluded.Hl. 18, Ill, 34-:1G The 
theory presents the same etiologic uncertainties which 
exist concerning the origins of human nephropathies 
produced by nonglomerular antigen-antibody COIl1-
plexes. 13 
A more likely available complex would be that be-
tween histocompatibility antigens and transplantation 
antibodies. ln, H In such a case, one of two possible 
sequences might occur. (1) Transplantation antigens are 
as yet only partially characterized both chemically and 
immunologically. 1, 2, 8, 9. 21, :il. 40 Therefore, weak and 
widely diffuse transplantation antigens might be pres-
ent in some components of glomerular and vascular 
basement membrane, where they react with antibodies 
of the hostK~o (2) Under conditions of intense immuno-
suppressive treatment, small amounts of circulating 
transplantation complexes may localize within vascular 
structures. An accumulation slower than glomerular 
catabolismll or a qualitatively different type of immune 
complex with strong affinity for glomerular basement 
membrane24 may account for the absence of the type of 
glomerular pathology usually associated with serum sick-
ness mechanisms.H, 11, 13. 14 This pathogenesis could be 
common both to allografts with linear and with granu-
lar fluorescence and may explain the pathologic simi-
larities observed in cases with focal linear and with 
focal granular stainings. The hypothesis that trans-
plantation antigens released from the graft30 may react 
with specific antibody and complement and then lodge 
in the glomeruli appears to be most important to es-
tablish. This pathogenetic mechanism could cover the 
variety of glomernlar lesions observed. 
In human patients and in rabbits with renal allo-
grafts, the formation of kidney-specific antibody and 
deposition of y-globulins along tubular basement mem-
branes have been described.23 , 4~ The experimental 
counterparts of tubular lesions similar to those observed 
in allografts RM, LD93, LD89, DH, and LD85 might 
be represented by allergic glomerulonephritis induced 
in rabbits with homologous renal antigens.43 However, 
in these studies, the deposits in tubular basement mem-
branes were believed to be the result of a reaction 
between host antibody and specific antigenic determi-
nants of tubular basement membranes. In allograft 
LD85 it was shown that aggregates of material binding 
ftuorescein- and ferritin-conjugated antibodies were 
seen in the glomeruli and also in the tubular lumina. 
Their accumulation on both sides of tubular basement 
membranes should be interpreted as owing to reabsorp-
tion of immunologic reactants filtered through injured 
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glomeruli. This hypothesis gains further support from 
the presence of deposits in Bowman's capsule. Therefore, 
the present study cannot provide evidence that an 
autoimmune reaction is responsible for tubular damage. 
In 12 allografts (see Tables 1 and 2), antibodies to 
immunoglobulins and complement localized in base-
ment membranes of arteries and veins and in the in-
creased amount of basement membrane-like material 
present between the smooth muscle cells of the ar-
teries.37 These findings are similar to studies on vascular 
localization of goat radioiodinated transplantation an-
tibodies~:l and on vascular localization of fluorescein-con-
jugated 195 and 7S globulin fractions eluted from 
canine renal allotrallsplants. 211 . ~d The localization of 
immunologic reactants in the ·walls of glomerular arte-
rioles (also observed in a new and larger series of allo-
grafts with acute or chronic rejection, presently under 
study3), suggests that histocompatibility antigens of 
\'ascular structures generate a marked antibody re-
sponse. a:l . 4H Such antibodies directed against vessels may 
also be influential in the production of rejection. 
In two allografts, LD89 and LD85, the granular de-
posits present between the smooth muscle cells of the 
media were similar to vascular deposits seen in rabbits 
with chroniL serum sickness." Therefore, these lesions 
were probably produced by prolonged exposure to 
circulati ng antigen-an ti body complexes. 
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